Glutamate-based Therapies for Psychiatric Disorders

1.
N-Methyl-d-Aspartate (NMDA) Antagonists for the Treatment of Depression
Phil Skolnick, Piotr Popik, Ramon Trullas

2. Ionic Glutamate Modulators in Depression (Zinc, Magnesium)
Bernadeta Szewczyk, Ewa Poleszak, Andrzej Pilc, Gabriel Nowak

3. Positive Allosteric Modulation of AMPA Receptors: A Novel Potential Antidepressant Therapy
Eric S. Nisenbaum, Jeffrey M. Witkin

4. Glutamatergic Modulators for the Treatment of Major Depressive Disorder: Metabotropic Glutamate Receptors
Jeffrey M. Witkin

5. Positive Modulation of AMPA Receptors as a Broad-Spectrum Strategy for Treating Neuropsychiatric Disorders
Gary Lynch, Julie C. Lauterborn, Christine M. Gall

6. Activation of Group II Metabotropic Glutamate Receptors (mGluR2 and mGluR3) as a Novel Approach for Treatment of Schizophrenia
Douglas J. Sheffler, P. Jeffrey Conn

7. mGluR1 Negative Allosteric Modulators: An Alternative Metabotropic Approach for the Treatment of Schizophrenia
Hisashi Ohta, Hiroshi Kawamoto, Gentaroh Suzuki

8. Metabotropic Glutamate Receptors as Targets for the Treatment of Drug and Alcohol Dependence
Svetlana Semenova, Athina Markou

9. Metabotropic Approaches to Anxiety
Joanna M. Wieronska, Gabriel Nowak, Andrzej Pilc

Nyckelord: Medicine & Public Health, Psychopharmacology, Pharmacology/Toxicology, Psychiatry, Neurosciences